In February 2017, the FDA approved Immunexpress's SeptiCyte, a molecular test with an indication for diagnosing sepsis on the first day of ICU treatment.
Share this post
Sepsis blood test with high accuracy may be…
Share this post
In February 2017, the FDA approved Immunexpress's SeptiCyte, a molecular test with an indication for diagnosing sepsis on the first day of ICU treatment.